Pyoderma gangrenosum presenting to an infectious diseases clinic: A 2024 case series.

Fabiana Kellen, Michael Silverman, Esfandiar Shojaei, MohammadReza Rahimi Shahmirzadi, Lili Ataie

Abstract readCase Reports

In one paragraph

Article in SAGE open medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fabiana KellenSchulich School of Medicine, Western University, London, ON, Canada.ORCID https://orcid.org/0009-0001-5101-2277

Michael SilvermanSchulich School of Medicine, Western University, London, ON, Canada.

Esfandiar ShojaeiSchulich School of Medicine, Western University, London, ON, Canada.ORCID https://orcid.org/0000-0002-4640-2561

MohammadReza Rahimi ShahmirzadiSchulich School of Medicine, Western University, London, ON, Canada.ORCID https://orcid.org/0000-0002-2410-6788

Lili AtaieSchulich School of Medicine, Western University, London, ON, Canada.ORCID https://orcid.org/0009-0000-0846-3534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyoderma gangrenosum is a rare neutrophilic dermatosis characterized by painful ulcerative skin lesions and a lack of definitive diagnostic tests. It is frequently mistaken for infectious conditions, often resulting in inappropriate antibiotic use and delayed immunosuppressive therapy. To describe the clinical and demographic characteristics of patients with pyoderma gangrenosum initially assessed in an infectious diseases setting and identify patterns that may aid in earlier diagnosis and management. A retrospective case series was conducted at a Cellulitis Clinic. Patients with a PARACELSUS score ⩾10 were included. Ten patients met inclusion criteria. Median age was 61.5 years; 60% were female and 90% Caucasian. Autoimmune diseases were present in 90%, mental health disorders in 50%, and endocrine abnormalities in 60%. Notably, 20% developed pyoderma gangrenosum at sites of healed scars-a rare presentation. Early recognition and multidisciplinary management are essential for timely treatment and improved outcomes.

Indexed as

non-healing ulcersPGpost-surgical pyoderma gangrenosumpyoderma gangrenosumpyoderma gangrenosum diagnosis

Identifiers

PMID42517131

DOI10.1177/2050313X261463941

PMCPMC13402762

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.